Improving cefazolin exposure in critically ill children using a population pharmacokinetic model.
Clémence RivaudMehdi OualhaElodie SalvadorEmmanuelle BilleDelphine CallotAgathe BérangerLeo Froelicher BournaudSteeve RouillonJulie ToubianaSihem BenaboudSylvain RenolleauJean Marc TreluyerDéborah HirtNoémie de CacquerayPublished in: British journal of clinical pharmacology (2024)
Use of individualized cefazolin model-informed dosing improves critically ill children's exposure. Further studies are needed to assess the clinical benefit of cefazolin PK model application.
Keyphrases